Additional Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Phoenix, AZ
    Phoenix AZ. 85032
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Champaign, IL
    Champaign IL. 61822
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Newport Beach, CA
    Newport Beach CA. 92663
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    Renstar Medical Research
    Ocala FL. 34470
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    University of Cincinnati
    Cincinnati OH. 45267
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    The University of Kansas Medical Center
    Kansas OH. 66160
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    Southeastern Research Center
    Winston-Salem NC. 27103
    View Details

  • An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

    Dynamic Drug Advancement
    Ajax ON.
    View Details

  • PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

    University of Washington
    Seattle WA. 98195
    View Details

  • PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

    University of British Columbia
    Vancouver BC. V6Z 1Y6
    View Details

  • PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

    University of Calgary
    Calgary AB. T2N 4Z6
    View Details

  • PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

    University of Texas Southwestern
    Dallas TX. 75390
    View Details

  • PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

    University of Virginia
    Charlottesville VA. 22908
    View Details

  • PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

    University of Michigan
    Ann Arbor MI. 48109
    View Details

  • PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

    University of Massachusetts Chan Medical School
    Worcester MA. 01655
    View Details

  • A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details

  • A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

    Piedmont Physicians Pulmonary & Sleep Medicine of Buckhead
    Atlanta GA. 30309
    View Details

  • A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

    University of Alabama at Birmingham
    Birmingham AL. 35233
    View Details

  • A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

    Northshore University Health System
    Evanston IL. 60201
    View Details

  • A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

    University of Nebraska Medical Center
    Omaha NE. 68198-1230
    View Details